ArticleBMJ public health2026
Impact of sensory impairments on the risk of mortality and hospitalisations: longitudinal insights from REGLINK-SHAREDK.
Article in BMJ public health, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Vision impairment (VI), hearing impairment (HI) and dual sensory impairment (DSI) are common conditions among older adults, significantly impacting health. Here, we examine associations between sensory impairments and risk of all-cause and cause-specific mortality and hospitalisations, and we explore whether these associations differ between men and women. Methods: We conducted a cohort study of 5700 individuals aged 40+ years interviewed in the Survey of Health, Ageing and Retirement in Europe (2004-2015) and followed in Danish registries until 2018. Cox and negative binomial regressions provided HRs and incidence rate ratios (IRRs) with 95% CIs, including sex interactions, enabling sex-specific estimates adjusted for sociodemographic and lifestyle factors. Results: During follow-up, 1058 deaths, 16 468 inpatient and 54 380 outpatient hospitalisations occurred. VI (HR 1.22; 95% CI 1.01 to 1.47), HI (HR 1.20; 95% CI 1.01 to 1.43) and DSI (HR 1.37; 95% CI 1.06 to 1.76) were associated with increased mortality. In sex-stratified analyses, the associations with VI (HR 1.49; 95% CI 1.14 to 1.95) and HI (HR 1.30; 95% CI 1.03 to 1.63) were evident in men. DSI was associated with higher mortality from endocrine, circulatory and respiratory diseases. Among others, VI and HI increased the risk of death from mental disorders among men. VI (IRR 1.22; 95% CI 1.06 to 1.41) and DSI (IRR 1.34; 95% CI 1.05 to 1.69) were associated with more inpatient hospitalisations, while HI was associated with more outpatient hospitalisations (IRR 1.08; 95% CI 1.01 to 1.17). Hospitalisation rates were notably elevated for respiratory and nervous system diseases. Conclusions: Sensory impairments are associated with increased risk of death and hospitalisation, particularly for men and specific types of diseases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.